SLC6A3 and movement disorder: In conjunction with patient medical history and clinical examination, evaluation of nigrostriatal dopamine transporters (DaT) in movement disorders can be performed with DaTscanTM (ioflupane iodine-123 [I123]) using single photon emission computed tomography (SPECT).